Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer
dc.contributor.author | Eskiizmir, G | |
dc.contributor.author | Koçal, GÇ | |
dc.contributor.author | Uysal, T | |
dc.contributor.author | Ellidokuz, H | |
dc.contributor.author | Baspinar, Y | |
dc.date.accessioned | 2024-07-18T11:53:30Z | |
dc.date.available | 2024-07-18T11:53:30Z | |
dc.description.abstract | Objectives To determine the serum hypoxia-inducible factor-1, -2 and -3 (HIF-1, -2 and -3) levels in patients with laryngeal neoplasm, and to investigate their role in differential diagnosis, prediction of tumour characteristic and extension, and prognosis and survival. Study Design Prospective, cohort study at a tertiary referral centre. Settings The study was conducted in a tertiary medical centre. Participants Patients with benign, premalignant and malignant laryngeal neoplasms were included. Sixty-four patients with a laryngeal neoplasm were enrolled. Main Outcome Measures Serum HIF-1, -2 and -3 levels were measured from blood samples that were drawn before treatment, using ELISA. Results A statistically significant difference between benign (HIF-1, -2, -3:4046,1 pg/mL; 2581,5 pg/mL; 1321,0 pg/mL), premalignant (HIF-1, -2, -3:3630,3 pg/mL; 3229,7 pg/mL; 2549,8 pg/mL) and malignant (HIF-1, -2, -3:3576,7 pg/mL; 2595,8 pg/mL; 1106,3 pg/mL) laryngeal neoplasms was not detected when serum HIF-1, -2 and -3 levels were compared. However, high serum HIF-2 level adversely affected survival and locoregional control and had more than 7-fold increase in hazard ratio. Moreover, serum HIF-2 was an independent prognostic factor for 2-year overall, disease-free, distant metastasis-free survival and locoregional control. Conclusion This is the first clinical study in which the diagnostic, predictive and prognostic roles of hypoxia-related biomolecules were examined in laryngeal neoplasms. Hypoxia-inducible factor-2 is a prognostic factor in larynx cancer irrespective of treatment modality. | |
dc.identifier.issn | 1749-4478 | |
dc.identifier.other | 1749-4486 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/5663 | |
dc.language.iso | English | |
dc.publisher | WILEY | |
dc.subject | SQUAMOUS-CELL CARCINOMA | |
dc.subject | TUMOR MICROENVIRONMENT | |
dc.subject | CA-IX | |
dc.subject | CLINICAL-RELEVANCE | |
dc.subject | PREDICTIVE-VALUE | |
dc.subject | GROWTH-FACTOR | |
dc.subject | RISK-FACTORS | |
dc.subject | HEAD | |
dc.subject | HIF-2-ALPHA | |
dc.subject | ANEMIA | |
dc.title | Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer | |
dc.type | Article |